Skip to main content

ixabepilone

Generic: IXABEPILONE·Brand: IXEMPRA KIT

ixabepilone: 2 clinical trials tracked.

ixabepilone evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about ixabepilone, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Metastatic Breast Cancer
Clinical Trial Registry Records (2)

Phase II, Open Label, Single Arm Study to Investigate Anti-tumor Effect of Ixabepilone in Patients With Locally Recurrent or Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP After Failure of an Anthracycline and Taxanes.

NCT04796324Registry updated 2026-03-12·Phase 2·ALLR
Terminated

Primary endpoint: Clinical Benefit Rate (CBR)

Interventionalopen13 targetStarted 2021-03Completion 2025-1119 sites · Belgium, Finland, Germany, Italy…Allarity Therapeutics

A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer

NCT00877500Registry updated 2026-05-22·Phase 2
Active, not recruiting

Primary endpoint: Genomic (transcriptional profiles) and proteomic (pathway activation) features that distinguish tumors

InterventionalRandomizedopen116 targetStarted 2009-03Completion 2026-123 sites · United StatesM.D. Anderson Cancer Center